Latest News and Press Releases
Want to stay updated on the latest news?
-
VANCOUVER, BRITISH COLUMBIA--(Marketwire - Feb. 7, 2013) - biOasis Technologies Inc. (TSX VENTURE:BTI) announced today that its Transcend-Herceptin® Conjugate (BT2111) product...
-
VANCOUVER, BRITISH COLUMBIA--(Marketwire - Dec. 14, 2012) - biOasis Technologies Inc. (TSX VENTURE:BTI) today is pleased to provide a 2012 year in review. biOasis has come a long way in...
-
VANCOUVER, BRITISH COLUMBIA--(Marketwire - Dec. 3, 2012) - biOasis Technologies Inc. (TSX VENTURE:BTI) announced today that it has entered into a research collaboration agreement with...
-
VANCOUVER, BRITISH COLUMBIA--(Marketwire - Nov. 14, 2012) - biOasis Technologies Inc. (TSX VENTURE:BTI) announced today that it has entered into a research and evaluation agreement with...
-
VANCOUVER, BRITISH COLUMBIA--(Marketwire - Sept. 24, 2012) - biOasis Technologies Inc. (TSX VENTURE:BTI) announces today positive results of a preliminary toxicity evaluation of test...
-
VANCOUVER, BRITISH COLUMBIA--(Marketwire - Sept. 5, 2012) - biOasis Technologies Inc. (TSX VENTURE:BTI) announced today that a key animal study in its BT2111 oncology program, showed that...
-
VANCOUVER, BRITISH COLUMBIA--(Marketwire - Aug. 28, 2012) - biOasis Technologies Inc. (TSX VENTURE:BTI) announces its board of directors elected by the shareholders at its Annual General...
-
VANCOUVER, BRITISH COLUMBIA--(Marketwire - July 19, 2012) - biOasis Technologies Inc. (TSX VENTURE:BTI) announces that is has granted options to its officers, employees, consultants and...
-
VANCOUVER, BRITISH COLUMBIA--(Marketwire - June 27, 2012) - biOasis Technologies Inc. (BTI) (TSX VENTURE:BTI) is pleased to announce that Mr. Gregory Gubitz has joined the Board of...
-
VANCOUVER, BRITISH COLUMBIA--(Marketwire - June 18, 2012) - biOasis Technologies Inc. (TSX VENTURE:BTI) announced today that it has entered into an agreement with Abbott, to evaluate...